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SUMMARY Positive airway pressure (PAP) is the most common form of treatment for obstructive
sleep apnea (OSA). Treatment adherence is notoriously low, and holidays from
treatment are common. To date, there is no literature on the effects of acute withdrawal
from PAP treatment on the brain activity of individuals with OSA. Nine participants
with OSA performed a 2-Back verbal working memory paradigm during repeated
functional magnetic resonance imaging (FMRI). Counterbalanced FMRI sessions were
under conditions of PAP treatment (at least one consecutive week) or non-treatment
(for two consecutive nights). Treatment effects on 2-Back-related brain activity were
significant, with greater deactivation in the right posterior insula and overactivation in
the right inferior parietal lobule. The observed responses to PAP treatment withdrawal
were more extreme in all regions of interest, such that 2-Back-related activity increased
and 2-Back-related deactivation decreased further relative to the 0-Back control task.
The withdrawal of PAP treatment in effectively treated individuals with OSA might
result in the need to reallocate resources in order to perform at the same cognitive level.
k e y w o r d s functional magnetic resonance imaging, neuroimaging, obstructive sleep
apnea, positive airway pressure, treatment, working memory
INTRODUCTION
Obstructive sleep apnea (OSA) is a serious medical condition
characterized by repeated complete or partial collapses of the
upper airways during sleep (Young et al., 2002), leading to
notable daytime sequelae (Aloia et al., 2004; Ancoli-Israel
et al., 1991; Nieto et al., 2000; Young et al., 1993). Although
cognitive complaints are common in OSA, the pattern of
deficits is less understood [for reviews see Aloia et al. (2004),
Beebe et al. (2003), and Fulda and Schulz (2001)]. Several
theories have been developed that consider various mecha-
nisms of cognitive dysfunction in OSA, including the effects of
sleep fragmentation, chronic sleep deprivation, neuronal cell
loss due to hypoxemia, and vascular compromise (Aloia et al.,
2004; Beebe, 2005; Beebe and Gozal, 2002; Lanfranchi and
Somers, 2001; Tonon et al., 2007; Verstraeten and Cluydts,
2004; Verstraeten et al., 2004). Common to all of these theories
is the potential for dysfunction of higher order cognitive skills.
Functional neuroimaging studies performed during cogni-
tive challenges can provide insight into the function and
dysfunction of neuroanatomical circuits of the brain. For
instance, under-representation (e.g., decreased activity) of a
particular region might be due either to neural loss or the need
to redistribute resources. Conversely, over-representation of a
region has been postulated to be a reflection of compensation
for inefficiencies somewhere else in the circuit [e.g., Drummond
and Brown (2001), Drummond et al. (1999), and Portas et al.
(1998)].
Despite the breadth of literature on cognitive dysfunction
in OSA, functional imaging paradigms during cognitive
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challenges have been used only recently in these patients. One
reason is the limitations of the technology to accommodate
participants with larger girths, therefore limiting the availabil-
ity of participants, given the increased prevalence of obesity in
this population. To date, only two studies have been published
that examine the magnetic resonance (MR) signal in patients
with OSA performing a cognitive challenge. Thomas et al.
(2005) presented averaged group activation maps that illus-
trated a lack of task-related blood oxygen level-dependent
(BOLD) signal activity in the dorsolateral prefrontal cortex in
16 untreated patients with OSA compared with matched
normal controls during a working memory challenge. In
addition, OSA participants performed significantly more
poorly and slowly on the working memory task compared
with controls. Six of these patients were also examined after a
minimum of 8 weeks of positive airway pressure (PAP)
treatment. Although patients demonstrated improvements in
their self-reported daytime sleepiness, a persistent lack of
working memory-related signal activation was evident in the
prefrontal cortex even after treatment. The authors note in
their discussion that additional studies are needed and should
be designed to address the question of cerebral recovery with
treatment.
The second study by Ayalon et al. (2006), examined the
functional magnetic resonance imaging (FMRI) response in
apnea compared with matched normal controls on a verbal
learning task. These investigators found increased activation in
several brain regions within the apnea group. Performing at
the same level as controls, the OSA patients recruited greater
brain volume in task-related areas as well as the recruitment of
additional regions, suggesting the need for compensatory
resources.
Positive airway pressure is the most common treatment for
OSA, yet adherence to PAP is notoriously low (1992) and
holidays from treatment are common. There has been only one
study examining the cognitive effects of acute withdrawal from
continuous PAP (CPAP) (Yang et al., 2006). This study
examined cognitive functioning at baseline, after successful
treatment, after withdrawal, and again after reintroduction of
treatment. Cognitive deficits were noted off-treatment and
were corrected only partially with treatment reintroduction.
Notably, the primary cognitive improvement was seen in
information processing speed and attention. To date, no study
has examined treatment differences (i.e., on- and off-treatment)
using FMRI methodology, and none have addressed the
common condition of PAP holidays. We employed the same
working memory task as Thomas et al. (2005) in a within-
subjects design to examine the effects of PAP treatment on
BOLD activity in OSA. Patients were studied in a counter-
balanced manner under conditions of treatment (for at least
two consecutive nights) and non-treatment (for at least two
consecutive nights). The current study assessed the reversibility
of the treatment effects reported by Thomas et al. In addition,
our methodology extends the previous work to examine the
effects of acute withdrawal of treatment, rather than examin-
ing treatment effects several weeks later in an untreated OSA
group. We hypothesized that patients would show a decreased
BOLD signal and worse performance under conditions of no
treatment compared with the treatment condition, with the
most prominent differences occurring in the posterior regions
[as reported by Thomas et al. (2005)] as well as the potential




Nine participants (four women; 75% Caucasian) were
recruited from a larger study on the effect of PAP treatment
on cognitive functioning conducted at the Sleep Disorders
Center of Lifespan Hospitals of Rhode Island (Felver-Gant
et al., 2007). All participants met criteria for OSA by a full
night of polysomnography. The common measure used to
diagnose OSA and describe respiratory disturbances during
sleep is the Apnea–Hypopnea Index (AHI); this index reflects
the ratio of episodes of apneas (i.e., complete cessation of
breathing for >10 s) and hypopneas (i.e., ‡ 50% reduction in
breath flow with subsequent desaturation of O2 levels for 10 s)
during sleep divided by hours of sleep time. OSA was
diagnosed if this AHI ratio was greater than 5 per hour.
Verbal intelligence quotient was estimated using the American
version of the National Adult Reading Test (Ryan and Paolo,
1992). Additional eligibility requirements included the follow-
ing: (i) age between 25 and 65 years; (ii) native English-
speaking; (iii) no comorbid medical or psychiatric disorder;
(iv) normal sleep–wake schedules as reported on daily diaries;
(v) adherence to PAP treatment (averaging >5 h per night for
at least 3 months) measured by objective monitoring of nightly
use; (vi) did not currently take medication (e.g., stimulants) to
treat the symptoms of OSA; and (vii) free of MRI contrain-
dications (e.g., capable of fitting into the MRI scanner, no
claustrophobia). Written informed consent was obtained for
all participants. This study was approved by the Institutional
Review Boards at Brown University and at the Memorial
Hospital of Rhode Island where scanning was performed.
Procedures
All participants received training on the 2-Back working
memory test. The 2-Back is used widely in FMRI research, and
therefore has the advantage of a well-described brain response
among patients and healthy volunteers [e.g., Braver et al.
(1997), Sweet et al. (2008), and Thomas et al. (2005)]. Training
was conducted first on a dedicated training day prior to any
scanning session and was repeated prior to each scanning
session. All participants were required to perform the 2-Back
task to the criterion of 80% accuracy before entering the
scanner. Scanning was conducted under two conditions: (i)
after at least one consecutive week on treatment and (ii) after
having refrained from PAP for two consecutive nights. The
treatment withdrawal period was restricted to two nights to
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mimic a treatment holiday and for the safety of the partici-
pants. Measures of objective adherence to PAP were obtained
throughout the course of the study using a microprocessor
housed within the PAP treatment device of each participant.
Adherence was monitored as a validity check for the on-
treatment phase of the study. Treatment condition was
counterbalanced. All participants were asked to refrain from
taking any medications, smoking cigarettes or drinking caffe-
inated beverages at least 3 h prior to each scanning session and
adherence was verified by interview. All participants who
enrolled in the study reported not having a current history of
smoking.
Measures of subjective sleepiness were also administered
before and after each scanning session using the Stanford
Sleepiness Scale (SSS). The SSS was designed to measure state
sleepiness and was utilized because we were interested in the
potential change in sleepiness associated with the scanning
session itself. Scores on the SSS range from 1 to 7, with higher
scores reflecting greater subjective sleepiness. Sleep diaries
were also obtained on the night prior to scanning to assure
similar total sleep time across sessions.
FMRI paradigm
The 2-Back is a verbal working memory task in which a series
of consonants are presented visually, one every 3000 ms.
Participants were asked to determine whether the letter they
saw was the same as or different from the consonant presented
two earlier (e.g., f, N, b, N, B, K, b, k, N, G…) and to make a
yes ⁄no response using a two-button response box following
each consonant (Fig. 1). Capitalization was randomized and
each consonant block contained 33% targets. Executive
coordination, phonemic buffering, and subvocal phonemic
rehearsal are required to perform this task successfully. In
addition to the 2-Back, the 0-Back control task required
participants to respond yes when they saw a predetermined
target consonant (X or x) and no for any other consonants.
This condition included consonants presented at the same rate
and with the same target frequency as the 2-Back. In total,
there were four 6-min imaging runs of four 0-Back ⁄ 2-Back
cycles each. The dependent variable generated for this study
was the number of correct responses under 500 ms. This cutoff
was reflective of conscious and attentive behavior and assured
that participants were not asleep during scanning.
FMRI acquisition
Whole-brain FMRI was conducted using a Siemens Sym-
phony 1.5 Tesla scanner (Erlangen, Germany). BOLD echo-
planar images were acquired in the axial plane using sufficient
contiguous 3-mm slices for whole brain coverage. Other
parameters were repetition time = 3840 ms, echo time =
38 ms, filed of view = 1922 mm, and matrix size = 642. This
procedure yielded 94 whole-brain volumes for each 6-min
imaging run, with a spatial resolution of 3 mm3 per voxel.
Whole-brain high-resolution 1 mm3 T1 images were also
acquired in the sagittal plane for anatomical reference.
FMRI data processing
Functional magnetic resonance imaging dataset processing
and statistical analyses were performed with Analysis of
Functional NeuroImages (AFNI) software (Cox, 1996;
National Institutes of Health, Bethesda, MD, USA). Concat-
onated 3D + time echoplanar datasets were spatially regis-
tered and temporally smoothed to minimize movement artifact
and improve reliability. A voxelwise, multiple regression
procedure was conducted to quantify the relationship between
2-Back task: 
0-Back control task: 
0-Back 
2-Back 2-Back 2-Back 2-Back 
0-Back 0-Back 0-Back 
Is the letter the same as 
the letter shown two earlier? 
Stimulus duration = 500 ms 
Inter-stimulus intervals = 2500 ms 
Is the letter an “X’’? 
Schematic of a sample blocked run Figure 1. An example of the 2-Back task.
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brain activity and the 2-Back paradigm. For each voxel of each
individual, a regression of the temporal pattern of 2-Back
presentation (including hemodynamic transitions modeled as a
gamma function) and 0-Back control task and covariates
(observed movement, linear drift) were performed using the
BOLD signal over time as the dependent variable. Resulting
individual activation maps of task-related effects expressed as
t-scores were resampled to a resolution of 1 mm3 and
transformed into standard stereotaxic space for use in region
of interest (ROI). A set of nine bilateral a priori ROIs were
selected from the results of our previously published FMRI
studies involving 34 healthy individuals performing the 2-Back
task (Sweet et al., 2008). Mean task-related activity across the
voxels in each ROI of each participant were used as dependent
measures in contrasts of PAP condition to test our hypotheses.
Group summary activation maps were also created by thres-
holding (two-tailed P < 0.001) one-sample voxelwise t-tests of
individual activation maps for each condition against a
hypothetical mean of zero (i.e., no differences between 0-Back
and 2-Back conditions). Clusters of significant activity smaller
than 200 mm3 were excluded from group summary activation
maps. In addition to qualitative contrasts of conditions, these
maps allowed comparisons to previous 2-Back functional
neuroimaging literature and provided evidence of the validity
of the a priori ROIs used to test our hypotheses.
RESULTS
Demographic characteristics of the participants are presented
in Table 1. Participants were generally middle-aged, highly
educated, and exhibited moderate (AHI: 15–30) to severe OSA
(AHI >30). On average, participants used PAP for 6.64 h per
night during the week prior to scanning for the on-treatment
condition. Objective adherence monitoring was used to verify
no use on the two nights prior to scanning in the off-treatment
condition. Total sleep time (taken from the sleep diaries on the
night previous to the scan), subjective sleepiness, and number
correct (under 500 ms) on the 2-Back task across treatment
conditions (on versus off PAP) are presented in Table 2. The
Wilcoxon-matched pair signed-ranks test was used to contrast
treatment conditions due to the small sample size and this tests
efficiency in determining effect size under non-normal distri-
butions. There was no difference for condition in self-reported
total sleep time (on = 7.57 versus off = 7.49, Z = )0.65,
P > 0.05). Participants endorsed greater subjective sleepiness
off-treatment prior to (on = 1.9 versus off = 3.4, Z = )2.56,
P < 0.05) and after (on = 2.4 versus off = 4.0, Z = )2.39,
P < 0.05) scanning. Differences in sleepiness attributed to
time in the scanner were not significant for either condition.
2-Back performance
Participants performance on the 2-Back task was greater than
chance, with sampled average accuracy means above 80% for
all trials. These performance levels did not differ by condition
(Z = )0.30, P > 0.05), suggesting that any differences in
brain activity across the PAP condition were not attributable
to differences in performance. High performance levels and a
lack of differences between PAP conditions were due probably
to the level of training that participants received prior to each
scanning session.
Brain activation
A priori ROIs are listed in detail in Table 3. Of the nine
bilateral regions, treatment effects were significant in the right
posterior insula and right inferior parietal lobule. There was a
trend for treatment effects in the right posterior cingulate and
left supplementary motor cortex (SMA). Note that activation
patterns for all regions became more extreme in the off-
treatment condition compared with the on-treatment condi-
tion, with the insula and posterior cingulate demonstrating
significantly greater deactivation and the pariental lobe and
SMA demonstrating significantly greater activation.
Significant brain activity associated with the 2-Back task on-
and off-PAP treatment is presented together with a priori ROIs
in Fig. 2. Ten clusters of at least 200 lL of significant activity
were identified using a voxel threshold of P < 0.001.
Although every ROI exhibited more extreme task-related
activity or deactivation off-treatment compared with on-
treatment, only the difference in the right medial frontal gyrus
was significant (r = 0.69, P < 0.05).
Relationships between performance and brain activity were
examined during the treatment withdrawal condition using
Spearmans rho. Better 2-Back performance (correct responses
under 500 ms) was associated significantly with less deactiva-
tion in the left posterior insula (rho = 0.745, P = 0.021) and
the right posterior cingulate (rho = 0.753, P = 0.019), with a
trend for the same effect in the left posterior cingulate
Table 1 Demographic characteristics of the sample
Variable Means (SD) Range
Age (years) 51.1 (9.3) 32–61
Education (years) 15.6 (3.2) 13–22
Body mass index (kg m)2) 30.6 (2.0) 28–34
AHI (# per h) 42.4 (28.2) 17–80
Estimated verbal IQ 113.1 (9.1) 95–127
AHI, Apnea–Hypopnea Index; IQ, intelligence quotient.
Table 2 Behavioral characteristics across conditions
Variable On-treatment Off-treatment Z-value P-value
SSS (total score out of 7)
Prescan 1.9 (0.33) 3.4 (1.1) )2.59 <0.05
Postscan 2.3 (0.87) 4.0 (1.3) )2.39 <0.05
TST (h per night) 7.94 (0.95) 7.47 (1.16) )0.83 0.41
Number accurate under 500 ms
2-Back 35.0 (31.4) 35.8 (41.5) )0.30 0.77
SSS, Stanford Sleepiness Scale; TST, total sleep time.
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(rho = 0.644, P = 0.061). Relationships to performance were
not significant for any of the regions that exhibited task-related
activation (P > 0.05).
We also examined the association between change in
activation of the a priori ROIs and sleepiness on the SSS
prior to scanning to determine whether or not activation was
influenced by clinical symptoms. Increased left posterior insula
deactivation was associated with greater sleepiness after the
removal of PAP (r = )0.89, P < 0.01).
DISCUSSION
The aim of this study was to determine the effects of acute
withdrawal from PAP on brain function in patients with OSA.
The study was unique, in that it was designed to mimic the
common occurrence of a treatment holiday by withdrawing
treatment in adherent participants. Results are therefore
applicable to common clinical situations. Previous studies
have suggested that OSA might compromise working memory
ability and the recruitment of task-related brain regions
compared with controls. Both overactivation as well as
underactivation have been reported in the literature (Ayalon
et al., 2006; Thomas et al., 2005) but only one of these studies
has also attempted to address the effects of treatment on brain
function. Thomas et al. (2005) demonstrated some increased
activation in posterior brain regions with the initiation of
treatment but no improvement was demonstrated in the
dorsolateral prefrontal cortex, which was implicated in base-
line assessments. Our study employed a within-subjects design
to contrast directly counterbalanced treatment conditions.
Thomas et al. (2005) findings were roughly consistent with our
noted increase in activation in the right inferior parietal lobule
but we also noted a decrease in activation with treatment in the
right posterior insula.
Overall brain response patterns to the 2-Back task in our
study were consistent with previous studies using this task in
non-apneic samples (Braver et al., 1997; Haley et al., 2007;
Sweet et al., 2004; Thomas et al., 2005). Areas of overlap
included large bilateral frontal and parietal clusters of
activity and large medial prefrontal and posterior cingulate
clusters of deactivation relative to the 0-Back control task.
Table 3 Treatment and laterality effects in regions of interest







x y z On Off Z P
Parahippocampal gyrus ±26 )36 )3 Right )0.19 )0.17 )0.18 0.86
Left )0.33 )0.42 )0.77 0.44
Paracentral lobule ±3 )24 47 Right 0.07 )0.27 )1.01 0.31
Left )0.42 )0.65 )0.65 0.51
Posterior insula ±37 )22 21 Right )0.20 )0.72 2.55 0.01
Left )0.27 )0.36 )0.30 0.77
Anterior insula ±30 22 5 Right 1.36 1.43 )0.41 0.69
Left 1.53 1.52 0.06 0.96
Middle frontal gyrus ±40 16 31 Right 0.82 0.84 )0.06 0.95
Left 0.78 0.86 )0.55 0.60
Inferior parietal lobule ±35 )47 44 Right 1.26 2.09 )2.83 0.05
Left 1.59 1.82 )0.83 0.43
Medial frontal gyrus ±5 56 7 Right )0.80 )0.76 )0.16 0.88
Left )1.87 )1.70 )0.93 0.38
Posterior cingulate ±5 )49 19 Right )0.71 )1.14 2.36 0.09
Left )1.99 )1.76 )0.71 0.49
Supplementary motor area ±5 18 47 Right 1.31 1.63 )0.86 0.41
Left 1.45 2.06 )2.21 0.09
ROI: region of interest.
Region labels refer to location of centroid coordinate; P-values are two-tailed.
Figure 2. Working memory-related brain activity and a priori regions
of interest. Black spheres indicate the location of bilateral a priori
regions of interest (ROIs) listed in Table 3 from Sweet et al. (2008).
Warm colors indicate recruited activity. Red: off-positive airway
pressure (PAP); orange: on-PAP; yellow: both conditions. Cool colors
indicate deactivation relative to the 0-Back baseline control task. Dark
blue: off-PAP; blue: on-PAP; light blue: both conditions.
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Treatment-specific differences were found in the right inferior
parietal lobule which exhibited relatively greater task-related
activity off-treatment compared with on-treatment. In addi-
tion, the right posterior cingulate deactivation associated with
this task decreased further after treatment withdrawal.
One of the regions identified in our study, the inferior
parietal lobule, has been implicated in attentional processing in
previous FMRI studies [see Cohen et al. (2008)]. This suggests
that patients withdrawn from treatment for only two nights
may require abnormally high levels of attentional processing to
perform this demanding cognitive task. Compensatory recruit-
ment of the inferior parietal lobe during verbal working
memory tasks has also been reported among multiple sclerosis
patients (Staffen et al., 2002; Sweet et al., 2006). It is unclear if
this over-recruitment will be evident after longer periods of
treatment withdrawal or whether this is a more acute response.
It is tempting to interpret the group activation maps presented
in Fig. 2 by qualitative examination of color differences. This
would lead us to see an overall pattern of overactivation off-
treatment, supporting more global compensation. It is impor-
tant, however, to rely more on the statistical analyses,
especially in cases of small samples.
Deactivation in the posterior cingulate during the 2-Back
task, even more so without treatment, and a significant
relationship between successful performance and activity off-
treatment also provide evidence for a possible compensatory
mechanism. A study of the effects of total sleep deprivation on a
complex navigational task reported similar brain behavior
responses to a complex navigational task (Strangman et al.,
2005). In their within-subjects cross-over design, Strangman
et al. found similar task performance, greater compensatory
activity in the right inferior parietal lobe, and greater deactiva-
tion of the right posterior cingulate among the sleep-deprived
group. Several studies have reported that the posterior cingulate
activation is related to the anticipatory directing of visual
attention (Small et al., 2003) and attention to self-awareness (see
Vogt and Laureys, 2005). Suspension of these processes,
observed as deactivation, would lead logically to less distract-
ibility and better concentration. Investigators employing differ-
ent types of cognitive challenges have also described similar
patterns of deactivation related to increased attentional focus.
For instance, using parametric variations of short-termmemory
andauditory discrimination load,McKiernan et al. (2003, 2006)
found that increases in difficulty level led to decreases in task-
unrelated thoughts and further deactivation in the posterior
cingulate. Sweet et al. (2008) found the greater posterior
cingulate, posterior insula, and temporal deactivation during a
distracting phonological similarity manipulation of the 2-Back
task. Other support for this notion is suggested by experimental
manipulation of attention by nicotine administration. Hahn
et al. (2007) observed improved performance on a test of
visuospatial attention associatedwith greater deactivation in the
posterior cingulate following nicotine administration to smok-
ers who had been minimally deprived of nicotine.
Analyses of the relationship between 2-Back performance
and brain response during withdrawal of treatment also
suggests that the additional deactivation in the posterior
cingulate is compensatory. Despite overall greater deactivation
relative to the treatment condition, those who exhibited the
least deactivation (relative to the 0-Back baseline control task)
in the posterior cingulate performed the most effectively. All
participants performed well above chance; therefore, those
who found it most difficult, but succeeded at the 2-Back task,
also exhibited the greatest deactivation (relative to baseline).
Two other findings emerged from our study. First, the self-
reported increase in sleepiness across conditions supports the
notion that, at least subjectively, these patients noticed func-
tional impairment when treatment was withdrawn. Secondly,
the results suggest that adherence to treatment must be
considered in further MRI studies of OSA considering the
potential confounds of treatment withdrawal on theMR signal.
We note limitations to our conclusions. First, the sample
size is relatively small. However, the commensurate SDs within
regions across treatment conditions suggests that differences
are not due to large variability between scans, which is one
concern in making a Type I error. There were several
pragmatic issues related to sample size that arose when
conducting this study. Many patients failed to reach the
adherence criterion set by the study, limiting the pool of
potential participants. We also found that obese patients with
apnea were less likely to be able to fit into the MRI scanner.
Along with stringent inclusion ⁄ exclusion criteria and a within-
subjects design, we have limited variability. Larger sample
studies must be conducted to replicate the findings reported
here, but such small sample studies provide at least initial
proof of the concept needed to support these larger studies. A
second limitation of the study is the lack of a sham control
condition for participants. It is possible that participants
performed differently across conditions because of a subjective
feeling that they should perform differently without treatment.
Although this remains a definite possibility, one would expect
decreased behavioral performance in the off-treatment condi-
tion if this were the dominant reason for these findings, which
was not the case in our study. Also, a withdrawal study is
inherently within subjects. Sham studies tend to be group
comparison studies as withdrawal from effective CPAP to
sham might break the blind in a within-subjects design.
Finally, hypercapnia during the withdrawal condition could
lead to global elevations in the BOLD signal. We know of no
reason that such elevations would result in regional rather than
global findings, but this remains possible. The possibility of an
interaction is also plausible, such that hypercapnia alters the
range between baseline and experimental condition.
Despite these limitations, we believe that these findings
represent a unique contribution to the study of cognitive
functioning in OSA. FMRI is a useful technique for examining
brain function and is being utilized increasingly in sleep
research. This is the first study to address treatment with-
drawal effects on brain activation in OSA. We believe that the
inclusion of this technique will add to the understanding on the
effects of sleep apnea on brain function and to the extent that
treatment influences such functioning.
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